Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis.
van Schouwenburg PA, Rispens T, Wolbink GJ. van Schouwenburg PA, et al. Nat Rev Rheumatol. 2013 Mar;9(3):164-72. doi: 10.1038/nrrheum.2013.4. Epub 2013 Feb 12. Nat Rev Rheumatol. 2013. PMID: 23399692 Review.
Neutralizing capacity of monoclonal and polyclonal anti-natalizumab antibodies: The immune response to antibody therapeutics preferentially targets the antigen-binding site.
van Schie KA, Kruithof S, van Schouwenburg PA, Vennegoor A, Killestein J, Wolbink G, Rispens T. van Schie KA, et al. Among authors: van schouwenburg pa. J Allergy Clin Immunol. 2017 Mar;139(3):1035-1037.e6. doi: 10.1016/j.jaci.2016.09.014. Epub 2016 Oct 4. J Allergy Clin Immunol. 2017. PMID: 27717666 No abstract available.
Using monoclonal antibodies as an international standard for the measurement of anti-adalimumab antibodies.
van Schouwenburg PA, Kruithof S, Wolbink G, Wouters D, Rispens T. van Schouwenburg PA, et al. J Pharm Biomed Anal. 2016 Feb 20;120:198-201. doi: 10.1016/j.jpba.2015.12.040. Epub 2015 Dec 28. J Pharm Biomed Anal. 2016. PMID: 26748377
Functional analysis of the anti-adalimumab response using patient-derived monoclonal antibodies.
van Schouwenburg PA, Kruithof S, Votsmeier C, van Schie K, Hart MH, de Jong RN, van Buren EE, van Ham M, Aarden L, Wolbink G, Wouters D, Rispens T. van Schouwenburg PA, et al. Among authors: van schie k, van buren ee, van ham m. J Biol Chem. 2014 Dec 12;289(50):34482-8. doi: 10.1074/jbc.M114.615500. Epub 2014 Oct 17. J Biol Chem. 2014. PMID: 25326381 Free PMC article. Review.
Nanomolar to sub-picomolar affinity measurements of antibody-antigen interactions and protein multimerizations: fluorescence-assisted high-performance liquid chromatography.
Rispens T, Ooijevaar-de Heer P, Derksen NI, Wolbink G, van Schouwenburg PA, Kruithof S, Aalberse RC. Rispens T, et al. Among authors: van schouwenburg pa. Anal Biochem. 2013 Jun 15;437(2):118-22. doi: 10.1016/j.ab.2013.02.027. Epub 2013 Mar 13. Anal Biochem. 2013. PMID: 23499975
Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation.
van Schouwenburg PA, Krieckaert CL, Rispens T, Aarden L, Wolbink GJ, Wouters D. van Schouwenburg PA, et al. Ann Rheum Dis. 2013 Oct;72(10):1680-6. doi: 10.1136/annrheumdis-2012-202407. Epub 2013 Jan 7. Ann Rheum Dis. 2013. PMID: 23300118
Monoclonal anti-citrullinated protein antibodies selected on citrullinated fibrinogen have distinct targets with different cross-reactivity patterns.
van de Stadt LA, van Schouwenburg PA, Bryde S, Kruithof S, van Schaardenburg D, Hamann D, Wolbink G, Rispens T. van de Stadt LA, et al. Among authors: van schouwenburg pa, van schaardenburg d. Rheumatology (Oxford). 2013 Apr;52(4):631-5. doi: 10.1093/rheumatology/kes371. Epub 2012 Dec 22. Rheumatology (Oxford). 2013. PMID: 23264551
Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation.
van Schouwenburg PA, van de Stadt LA, de Jong RN, van Buren EE, Kruithof S, de Groot E, Hart M, van Ham SM, Rispens T, Aarden L, Wolbink GJ, Wouters D. van Schouwenburg PA, et al. Among authors: van de stadt la, van buren ee, van ham sm. Ann Rheum Dis. 2013 Jan;72(1):104-9. doi: 10.1136/annrheumdis-2012-201445. Epub 2012 Jul 3. Ann Rheum Dis. 2013. PMID: 22759910
IgG4 production against adalimumab during long term treatment of RA patients.
van Schouwenburg PA, Krieckaert CL, Nurmohamed M, Hart M, Rispens T, Aarden L, Wouters D, Wolbink GJ. van Schouwenburg PA, et al. J Clin Immunol. 2012 Oct;32(5):1000-6. doi: 10.1007/s10875-012-9705-0. Epub 2012 May 24. J Clin Immunol. 2012. PMID: 22622790
Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up.
Bartelds GM, Krieckaert CL, Nurmohamed MT, van Schouwenburg PA, Lems WF, Twisk JW, Dijkmans BA, Aarden L, Wolbink GJ. Bartelds GM, et al. Among authors: van schouwenburg pa. JAMA. 2011 Apr 13;305(14):1460-8. doi: 10.1001/jama.2011.406. JAMA. 2011. PMID: 21486979
22 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback